Notice Pursuant to Section 708(5)(e) of the Corporations Act 2001

Imagion Biosystems gives notice that, on 20 October 2020 the Company issued 2,401,900 fully paid ordinary shares (Shares) in the Company as the result of…


IBX Secures Additional Capital — Shareholders Exercise Options

Imagion Biosystems announced that it has received a total of $143,157 for the exercise of options. Composed of $142,200 for 2,370,000 options exercisable at 6…


Imagion Biosystems Appoints Geoff Hollis as CFO

Imagion Biosystems has appointed Geoff Hollis as Chief Financial Officer. The appointment strengthens the Company’s management and leadership team as the…